ArticleEuropean radiology experimental2026
Bridging radiomics and histopathology: cross-modality consistency of radiomic features from CT to micro-CT in NSCLC.
Article in European radiology experimental, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
objectiveRadiomics extracts quantitative features from medical images that may provide non-invasive biomarkers of tumor biology and heterogeneity. However, few studies have explored radiomics on micro-computed tomography (micro-CT) or its transferability to clinical CT. This study investigates the reproducibility and the potential biological correlation of radiomic features across in vivo CT, ex vivo CT, and ex vivo micro-CT in non-small-cell lung cancer (NSCLC). MATERIALS AND
methodsA retrospective cohort of 60 NSCLC patients with preoperative CT scans and surgical specimens was analyzed. Ex vivo CT and micro-CT images were acquired and compared with in vivo CT using standardized preprocessing, including normalization, resampling, and registration. Tumor regions of interest (ROIs) were semi-automatically segmented, and 93 radiomic features were extracted with Pyradiomics. Cross-modality reproducibility and associations with histotype were evaluated using Spearman correlation, intraclass correlation coefficient, Bland-Altman analysis, and Mann-Whitney U test.
resultsNormalization and volume matching improved feature repeatability, with the highest agreement observed in normalized datasets using subsampled ROIs. Four texture-based features consistently showed high reproducibility and potential biological correlation, likely reflecting intratumoral heterogeneity and variation in cell density: DependenceNonUniformity, GrayLevelNonUniformity (GLDM and GLRLM), and Coarseness (NGTDM). These features reliably distinguished adenocarcinoma from squamous cell carcinoma across modalities, confirming their stability and potential as candidate features for transferable biomarkers.
conclusionHarmonization and volume standardization are essential for cross-modality radiomic analyses. Stable texture features provide a potential transferable signature bridging micro-CT and clinical CT imaging in NSCLC, supporting their role as candidate features for further investigation in biologically oriented studies. KEY POINTS: Question Micro-CT serves as an intermediate imaging scale enabling radiomic feature extraction from ex vivo NSCLC tumors, allowing direct comparison with in vivo and ex vivo CT. Findings Intensity normalization and volume-matched subsampling between in vivo CT, ex vivo CT, and micro-CT reduced cross-modality feature variability, improving feature reproducibility. Relevance statement Normalization, volume matching, and cross-modality analysis support the identification of candidate texture features with consistent cross-scale behavior and exploratory associations with NSCLC histotype.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.